Get started
Author

Asurayya Worrede

Observed names: A Worrede-Mahdi, Asurayya A. Worrede-Mahdi, Asurayya Worrede-Mahdi
ORCID: 0000-0003-2013-0112
Observed ORCID: 0000-0003-2013-0112
OpenAlex ID: A5015246723
Cooperation among heterogeneous prostate cancer cells in the bone metastatic niche
2016 · K Shahriari, F Shen, et al. · Oncogene · 56
The dark side of daylight: photoaging and the tumor microenvironment in melanoma progression
2021 · Asurayya Worrede, Stephen M. Douglass, et al. · Journal of Clinical Investigation · 46
PDF
Limiting tumor seeding as a therapeutic approach for metastatic disease
2019 · Asurayya Worrede, Olimpia Meucci, et al. · Pharmacology & Therapeutics · 10
IL1β Expression Driven by Androgen Receptor Absence or Inactivation Promotes Prostate Cancer Bone Metastasis
2022 · Anthony DiNatale, Asurayya Worrede, et al. · Cancer Research Communications · 9
Impeding Circulating Tumor Cell Reseeding Decelerates Metastatic Progression and Potentiates Chemotherapy
2018 · Chen Qian, Asurayya Worrede-Mahdi, et al. · Molecular Cancer Research · 7
Abstract 5191: Targeting CX3CR1 Impairs the reseeding and colonization of circulating tumor cells and decelerates metastatic progression
2018 · Chen Qian, Asurayya Worrede-Mahdi, et al. · Cancer Research · 7
Abstract 5799: Targeting CX3CR1 impairs the reseeding of cancer cells recirculating from metastatic tumors
2017 · Chen Qian, Asurayya Worrede-Mahdi, et al. · Cancer Research · 1
Abstract 4303: AZD2284: A novel, alpha-particle emitting radioconjugate targeting STEAP2 in metastatic castration-resistant prostate cancer
2025 · Darlene Monlish, Brigitte Thériault, et al. · Cancer Research
Abstract 1158: Preclinical characterization of AZD0516, a novel STEAP2 antibody-drug conjugate (ADC) for the treatment of prostate cancer
2025 · Darlene Monlish, Vanessa Muniz-Medina, et al. · Cancer Research
Supplementary Figure 1 from Impeding Circulating Tumor Cell Reseeding Decelerates Metastatic Progression and Potentiates Chemotherapy
2023 · Chen Qian, Asurayya Worrede-Mahdi, et al.
PDF
Data from Impeding Circulating Tumor Cell Reseeding Decelerates Metastatic Progression and Potentiates Chemotherapy
2023 · Chen Qian, Asurayya Worrede-Mahdi, et al.
Data from Impeding Circulating Tumor Cell Reseeding Decelerates Metastatic Progression and Potentiates Chemotherapy
2023 · Chen Qian, Asurayya Worrede-Mahdi, et al.
Data from IL1β Expression Driven by Androgen Receptor Absence or Inactivation Promotes Prostate Cancer Bone Metastasis
2023 · Anthony DiNatale, Asurayya Worrede, et al.
Figure S3 from IL1β Expression Driven by Androgen Receptor Absence or Inactivation Promotes Prostate Cancer Bone Metastasis
2023 · Anthony DiNatale, Asurayya Worrede, et al.
Figure S1 from IL1β Expression Driven by Androgen Receptor Absence or Inactivation Promotes Prostate Cancer Bone Metastasis
2023 · Anthony DiNatale, Asurayya Worrede, et al.
Figure S4 from IL1β Expression Driven by Androgen Receptor Absence or Inactivation Promotes Prostate Cancer Bone Metastasis
2023 · Anthony DiNatale, Asurayya Worrede, et al.
Figure S4 from IL1β Expression Driven by Androgen Receptor Absence or Inactivation Promotes Prostate Cancer Bone Metastasis
2023 · Anthony DiNatale, Asurayya Worrede, et al.
Figure S2 from IL1β Expression Driven by Androgen Receptor Absence or Inactivation Promotes Prostate Cancer Bone Metastasis
2023 · Anthony DiNatale, Asurayya Worrede, et al.
Table TS2 from IL1β Expression Driven by Androgen Receptor Absence or Inactivation Promotes Prostate Cancer Bone Metastasis
2023 · Anthony DiNatale, Asurayya Worrede, et al.
Table TS1 from IL1β Expression Driven by Androgen Receptor Absence or Inactivation Promotes Prostate Cancer Bone Metastasis
2023 · Anthony DiNatale, Asurayya Worrede, et al.
PDF
Abstract B203: Heterogeneity in androgen receptor and IL-1beta expression by prostate cancer cells in skeletal metastases
2018 · Asurayya A. Worrede-Mahdi, Alessandro Fatatis · Molecular Cancer Therapeutics
Abstract B054: Impairing the reseeding of circulating tumor cells decelerates metastatic progression
2018 · Chen Qian, Asurayya Worrede-Mahdi, et al. · Molecular Cancer Therapeutics
Abstract 5804: Heterogeneity in androgen receptor and IL-1beta expression by prostate cancer cells in skeletal metastases
2017 · Asurayya A. Worrede-Mahdi, Melisa Diaz, et al. · Cancer Research
Works count: 23
Citation count: 136
H-index: 6
I10-index: 3
Year
Topic
Type